We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+13.64%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$744B
AUM Growth
+$61.8B
Cap. Flow
-$20.1B
Cap. Flow %
-2.7%
Top 10 Hldgs %
31.13%
Holding
2,974
New
92
Increased
1,834
Reduced
805
Closed
67

Top Buys

Rank Stock Value
1
DG icon
Dollar General
DG
+$1.37B
2
INTC icon
Intel
INTC
+$1.28B
3
SCHW
Charles Schwab
SCHW
+$1B
4
NKE icon
Nike
NKE
+$859M
5
UBER icon
Uber
UBER
+$825M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.67B
2
AMZN icon
Amazon
AMZN
+$2.15B
3
NVDA icon
NVIDIA
NVDA
+$1.64B
4
HUM icon
Humana
HUM
+$1.57B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.33B

Sector Composition

Rank Sector Weight
1 Technology 31.09%
2 Healthcare 15.81%
3 Financials 11.13%
4 Consumer Discretionary 10.82%
5 Communication Services 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLLY icon
2776
Holley
HLLY
$364M
$60K ﹤0.01%
12,276
+814
+7% +$3.6K
LAB icon
2777
Standard BioTools
LAB
$304M
$60K ﹤0.01%
26,800
-11,600
-30% -$24.8K
ASXC
2778
DELISTED
Asensus Surgical, Inc.
ASXC
$60K ﹤0.01%
185,500
AP icon
2779
Ampco-Pittsburgh
AP
$194M
$59K ﹤0.01%
21,600
AHT
2780
Ashford Hospitality Trust
AHT
$20M
$58K ﹤0.01%
2,970
WVVI icon
2781
Willamette Valley Vineyards
WVVI
$11.5M
$58K ﹤0.01%
10,850
ANNX icon
2782
Annexon
ANNX
$863M
$57K ﹤0.01%
+12,509
New +$31K
CDXS icon
2783
Codexis
CDXS
$177M
$57K ﹤0.01%
18,480
-29,376
-61% -$63.1K
FTCI icon
2784
FTC Solar
FTCI
$40.3M
$57K ﹤0.01%
8,165
+3,380
+71% +$30.7K
HFFG icon
2785
HF Foods Group
HFFG
$97M
$57K ﹤0.01%
+10,492
New +$47.7K
NN icon
2786
NextNav
NN
$3.32B
$57K ﹤0.01%
12,620
+482
+4% +$2.18K
VNDA icon
2787
Vanda Pharmaceuticals
VNDA
$305M
$57K ﹤0.01%
13,399
+1,244
+10% +$5.02K
NAGE
2788
Niagen Bioscience
NAGE
$241M
$57K ﹤0.01%
39,300
MYPS icon
2789
PLAYSTUDIOS Inc
MYPS
$67.3M
$56K ﹤0.01%
20,570
+2,268
+12% +$6.18K
STIM icon
2790
Neuronetics
STIM
$231M
$56K ﹤0.01%
19,100
PSTX
2791
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$56K ﹤0.01%
16,537
+2,706
+20% +$6.97K
CRDF icon
2792
Cardiff Oncology
CRDF
$80.9M
$55K ﹤0.01%
36,500
INZY
2793
DELISTED
Inozyme Pharma
INZY
$55K ﹤0.01%
+12,696
New +$45.1K
PHLT
2794
DELISTED
Performant Healthcare Inc
PHLT
$55K ﹤0.01%
17,563
+2,882
+20% +$7.55K
ITI
2795
DELISTED
Iteris, Inc.
ITI
$55K ﹤0.01%
+10,387
New +$45.8K
GTHX
2796
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$55K ﹤0.01%
17,755
SRTA
2797
Strata Critical Medical Inc
SRTA
$531M
$54K ﹤0.01%
15,255
+2,408
+19% +$6.91K
RFL icon
2798
Rafael Holdings
RFL
$108M
$54K ﹤0.01%
29,731
SLDP icon
2799
Solid Power
SLDP
$543M
$54K ﹤0.01%
36,636
AMTX icon
2800
Aemetis
AMTX
$127M
$53K ﹤0.01%
10,100

Similar funds

T. Rowe Price Associates's Q4 2023 Portfolio in Review

As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
  • T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
  • T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
  • T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
  • T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
  • T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
  • T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.

Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.